Though it is widely accepted that PCOS is characterised by insulin resistance (4), there is no consensus, either regarding the best method of assessment of insulin resistance (IR) in PCOS, nor in terms of the utility of such assessment for subsequent clinical management, such as indications for treatment with insulin-sensitising agents (5). The gene discussed is INS; the disease is Insulin resistance.